ConductScience.org, home

Paper74641

Bacteroides fragilis resistant to metronidazole after long-term therapy.

Ingham HR and 3 others. Lancet, 1978. Cited by 116 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Bacteroides fragilis resistant to metronidazole after long-term therapy. Papers, record 74641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/74641

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Bacteroides fragilis resistant to metronidazole after long-term therapy.
PubMed
Journal
Lancet
PubMed
Year
1978
PubMed
Publication types
Case Reports, Letter
PubMed
Citations, by iCite
116
iCite
Relative citation ratio, by iCite
5.59
iCite
Revised in PubMed
2019-06-10
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ingham HRH R
2Eaton SS
3Venables CWC W
4Adams PCP C

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bacteroides InfectionsMajor topic
Bacteroides fragilisMajor topic
MetronidazoleMajor topic
Adult
Drug Resistance, Microbial
Humans
Male
Time Factors

Source PubMed

Download CSV of topics

Cited by24

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 116 citations.

PMIDTitleJournalYearIn PapersSource
37711381Amidinoquinoxaline N-oxides: synthesis and activity against anaerobic bacteria.RSC Adv2023https://conductscience.org/library/papers/37711381PubMed
37374976Recent Trends in Antimicrobial Resistance among Anaerobic Clinical Isolates.Microorganisms2023https://conductscience.org/library/papers/37374976PubMed
37073211Phenotypic and Genotypic Correlation of Antimicrobial Susceptibility of Bacteroides fragilis: Lessons Learnt.Cureus2023https://conductscience.org/library/papers/37073211PubMed
36140015Derivation of a Precise and Consistent Timeline for Antibiotic Development.Antibiotics (Basel)2022https://conductscience.org/library/papers/36140015PubMed
27429642Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA).World J Emerg Surg2016https://conductscience.org/library/papers/27429642PubMed
24277041Metronidazole and hydroxymetronidazole central nervous system distribution: 1. microdialysis assessment of brain extracellular fluid concentrations in patients with acute brain injury.Antimicrob Agents Chemother2014https://conductscience.org/library/papers/24277041PubMed
22858695Mechanisms of action of systemic antibiotics used in periodontal treatment and mechanisms of bacterial resistance to these drugs.J Appl Oral Sci2012https://conductscience.org/library/papers/22858695PubMed
16208024Bacteremia caused by a metronidazole-resistant Prevotella sp. strain.J Clin Microbiol2005https://conductscience.org/library/papers/16208024PubMed
15364999Isolation of metronidazole-resistant Bacteroides fragilis carrying the nimA nitroreductase gene from a patient in Washington State.J Clin Microbiol2004https://conductscience.org/library/papers/15364999PubMed
15273153nimE gene in a metronidazole-susceptible Veillonella sp. strain.Antimicrob Agents Chemother2004https://conductscience.org/library/papers/15273153PubMed
9350755Vaginal carriage of enterotoxigenic Bacteroides fragilis in pregnant women.J Clin Microbiol1997https://conductscience.org/library/papers/9350755PubMed
8862561Detection by PCR of the nim genes encoding 5-nitroimidazole resistance in Bacteroides spp.J Clin Microbiol1996https://conductscience.org/library/papers/8862561PubMed
7081970Interaction of metronidazole with resistant and susceptible Bacteroides fragilis.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/7081970PubMed
7000306Mechanisms of selective toxicity of metronidazole and other nitroimidazole drugs.Br J Vener Dis1980https://conductscience.org/library/papers/7000306PubMed
6367636Interaction of metronidazole with DNA repair mutants of Escherichia coli.Antimicrob Agents Chemother1984https://conductscience.org/library/papers/6367636PubMed
3743557Isolation of Bacteroides strains with reduced sensitivity to 5-nitroimidazoles.Eur J Clin Microbiol1986https://conductscience.org/library/papers/3743557PubMed
3649203Susceptibility to five antimicrobial agents of strains of the Bacteroides fragilis group isolated in Brazil.Antimicrob Agents Chemother1987https://conductscience.org/library/papers/3649203PubMed
1396757Changes in the susceptibility of Bacteroides fragilis group organisms to various antimicrobial agents 1979-1989.Eur J Clin Microbiol Infect Dis1992https://conductscience.org/library/papers/1396757PubMed
1295762German multicentre study on the in vitro susceptibility of Bacteroides species. The German Bacteroides Study Group.Eur J Clin Microbiol Infect Dis1992https://conductscience.org/library/papers/1295762PubMed
718156Comparative susceptibilities of anaerobic bacteria to metronidazole, ornidazole, and SC-28538.Antimicrob Agents Chemother1978https://conductscience.org/library/papers/718156PubMed

See all 24 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/74641

GET https://conductscience.org/api/papers/v1/74641/cited_by?page=2